Mi Dendream, you wrote 'the only measure worth watching is approval'. Imo that could well take to end of 2022, at least in USA as it is still a long process - writing and submitting the bla and getting fda review during a pandemic I'm just hoping for a published technical paper and pr of tld and then a good presentation at asco 2022. My hope is the paper and tld will greatly support share price, approval may still be quite some time off Good luck